Items Tagged ‘San Antonio Breast Cancer Symposium’

January 22, 2015

Mayo Clinic in the News Weekly Highlights

By Karl W Oestreich KarlWOestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations   Star Tribune Mayo fights stricter oversight of […]

View full entry

Tags: Abatacept Dose, ABC 15 Arizona, ABC News, ABC15's Rally for Red, ACR's Dose Index Registry, aeromedical exam, Al Vogt, Alice Howland, Alternative Methods of Telehealth, AMD, America Cooks with Chefs, American College of Surgeons’ Commission


December 12, 2014

Mayo Clinic in the News Weekly Highlights

By Karl W Oestreich KarlWOestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations   Wall Street Journal Mayo CEO: Focus on […]

View full entry

Tags: animal therapy, antibiotics, Arizona Research Consortium and Mayo Clinic, Austin Business Journal, AZO Nano, Baby Boomers and health care, Barron News-Shield, Becker’s Hospital Review, BetaBoston (Boston Globe), big data and health care, Bill Marriott, BioWorld


February 20, 2013

When Is Less Surgery Beneficial in Breast Cancer?

By Logan Lafferty loganlafferty

Dr. Lidia Schapira, of Harvard Medical School and Massachusetts General Hospital, spoke to the Mayo Clinic’s Judy C. Boughey, MD, about the ACOSOG Z1071 trial, which looked at whether patients who had axillary lymph node involvement before neoadjuvant chemotherapy and who had a good response to systemic therapy could avoid axillary lymph node dissection. The […]

View full entry

Tags: axillary lymph node dissection, Dr. Judy Boughey, Dr. Lidia Schapira, Harvard Medical School, Massachusetts General Hospital, Medscape, San Antonio Breast Cancer Symposium, systemic therapy


January 26, 2012

Zoledronic Acid Controversy in Breast Cancer Continues

By

A growing body of evidence backs the contention that bisphosphonates can improve survival in breast cancer patients with low estrogen levels. The results of three studies of bisphosphonates in this setting presented at the recent San Antonio Breast Cancer Symposium (SABCS) support the low estrogen hypothesis, whereas interim results of a fourth trial presented there […]

View full entry

Tags: Breast Cancer, Dr. James Ingle, estrogen levels, oncology, San Antonio Breast Cancer Symposium


Contact Us · Privacy Policy